Literature DB >> 29748371

miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.

Mohamed Salem1, Jacob A O'Brien1, Stefanie Bernaudo1, Heba Shawer2, Gang Ye1, Jelena Brkić1, Asma Amleh2, Barbara C Vanderhyden3, Basel Refky4, Burton B Yang5, Sergey N Krylov6,7, Chun Peng8,7.   

Abstract

miRNAs play important roles in gene regulation, and their dysregulation is associated with many diseases, including epithelial ovarian cancer (EOC). In this study, we determined the expression and function of miR-590-3p in EOC. miR-590-3p levels were higher in high-grade carcinoma when compared with low-grade or tumors with low malignant potential. Interestingly, plasma levels of miR-590-3p were significantly higher in patients with EOC than in subjects with benign gynecologic disorders. Transient transfection of miR-590-3p mimics or stable transfection of mir-590 increased cell proliferation, migration, and invasion. In vivo studies revealed that mir-590 accelerated tumor growth and metastasis. Using a cDNA microarray, we identified forkhead box A2 (FOXA2) and versican (VCAN) as top downregulated and upregulated genes by mir-590, respectively. miR-590-3p targeted FOXA2 3' UTR to suppress its expression. In addition, knockdown or knockout of FOXA2 enhanced cell proliferation, migration, and invasion. Overexpression of FOXA2 decreased, whereas knockout of FOXA2 increased VCAN mRNA and protein levels, which was due to direct binding and regulation of the VCAN gene by FOXA2. Interrogation of the TCGA ovarian cancer database revealed a negative relationship between FOXA2 and VCAN mRNA levels in EOC tumors, and high FOXA2/low VCAN mRNA levels in tumors positively correlated with patient survival. Finally, overexpression of FOXA2 or silencing of VCAN reversed the effects of mir-590. These findings demonstrate that miR-590-3p promotes EOC development via a novel FOXA2-VCAN pathway.Significance: Low FOXA2/high VCAN levels mediate the tumor-promoting effects of miR-590-3p and negatively correlate with ovarian cancer survival. Cancer Res; 78(15); 4175-90. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29748371     DOI: 10.1158/0008-5472.CAN-17-3014

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

Review 1.  Versican: A Dynamic Regulator of the Extracellular Matrix.

Authors:  Shamima Islam; Hideto Watanabe
Journal:  J Histochem Cytochem       Date:  2020-09-10       Impact factor: 2.479

2.  Construction of a transcription factor-miRNA-mRNA interactive network elucidates underlying pathogenesis for osteosarcoma and validation by qRT-PCR.

Authors:  Fuxing Tang; Xiaohong Jiang; Shijie Liao; Yun Liu; Maolin He
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

3.  Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma.

Authors:  Li-Na You; Qin-Wen Tai; Lin Xu; Yi Hao; Wen-Jia Guo; Qiao Zhang; Qing Tong; Heng Zhang; Wu-Kui Huang
Journal:  Cancer Gene Ther       Date:  2021-01-07       Impact factor: 5.987

4.  TRPM2-AS promotes the malignancy of osteosarcoma cells by targeting miR-15b-5p/PPM1D axis.

Authors:  Yingchun Cai; Yudan Yang; Xudong Zhang; Qingqing Ma; Mengyi Li
Journal:  Cell Cycle       Date:  2022-01-31       Impact factor: 5.173

5.  miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer.

Authors:  Xiaoxiang Chen; Xueni Xu; Bei Pan; Kaixuan Zeng; Mu Xu; Xiangxiang Liu; Bangshun He; Yuqin Pan; Huiling Sun; Shukui Wang
Journal:  Aging (Albany NY)       Date:  2018-11-26       Impact factor: 5.682

6.  Effects of miR‑103a‑3p on the autophagy and apoptosis of cardiomyocytes by regulating Atg5.

Authors:  Chenjun Zhang; Chenjun Zhang; Hairong Wang; Yuan Qi; Ying Kan; Zhiru Ge
Journal:  Int J Mol Med       Date:  2019-03-12       Impact factor: 4.101

7.  Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.

Authors:  Yichen Song; Lianqi Shao; Yixue Xue; Xuelei Ruan; Xiaobai Liu; Chunqing Yang; Jian Zheng; Shuyuan Shen; Jiajia Chen; Zhen Li; Yunhui Liu
Journal:  J Exp Clin Cancer Res       Date:  2019-06-11

8.  Development of cancer prognostic signature based on pan-cancer proteomics.

Authors:  Weiguo Huang; Jianhui Chen; Wanqing Weng; Yukai Xiang; Hongqi Shi; Yunfeng Shan
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

9.  MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.

Authors:  Suogang Wang; Geng Zhang; Wanxiang Zheng; Qin Xue; Di Wei; Yu Zheng; Jianlin Yuan
Journal:  Biosci Rep       Date:  2018-12-07       Impact factor: 3.840

10.  INHBA promotes the proliferation, migration and invasion of colon cancer cells through the upregulation of VCAN.

Authors:  Jia Guo; Yuan Liu
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.